Cutibacterium acnes: not the villain we thought it was

Cutibacterium acnes lives on the skin of virtually everyone, whether they have acne or not. What differentiates those who develop the condition is not the presence of this bacterium, but which of its variants predominate. The latest research has identified distinct types of C. acnes with very different behaviours: type IA produces more biofilm and more lipid-degrading enzymes and is the most closely associated with follicular inflammation. Type II, on the other hand, behaves as a commensal and contributes to maintaining the skin’s equilibrium.

This distinction changes the way treatment is understood. Eliminating C. acnes indiscriminately with antibiotics not only destroys the pathogenic strains, but also the protective ones. The long-term result can be an impoverished cutaneous microbiome, more vulnerable to future relapses and to colonisation by resistant bacteria. The modern therapeutic goal is not eradication, but rebalancing.

 

The gut-skin axis: how your digestion influences your acne

The gut microbiota and the cutaneous microbiota communicate bidirectionally through what science refers to as the gut-skin axis. When the bacterial balance of the intestine is disrupted (by a diet rich in ultra-processed foods, high glycaemic index foods, chronic stress, or prolonged antibiotic use) intestinal mucosal permeability increases, levels of pro-inflammatory cytokines in the blood rise, and androgen production is altered. All of these factors worsen acne.

Diet plays a specific and well-documented role. Excess glucose spikes facilitate biofilm formation by the pathogenic strains of C. acnes, whilst certain compounds such as xylitol have been shown to inhibit it. High glycaemic index foods activate the insulin/IGF-1 pathway, which stimulates sebum production and follicular hyperkeratinisation. Whilst direct clinical evidence in acne remains an active line of research, the data on the mechanisms of action are robust.

 

Oral probiotics for acne: what does the science say?

The use of probiotics in acne has moved beyond speculation. The most relevant clinical trial currently available is a randomised double-blind study conducted in Spain, published in the journal Acta Dermato-Venereologica in 2024, involving 74 patients aged between 12 and 30 years. After 12 weeks of treatment with Lacticaseibacillus rhamnosus CECT 30031 combined with Arthrospira platensis, 50% of patients in the probiotic group showed improvement in their acne, compared to 29.4% in the placebo group. The reduction in non-inflammatory lesions was highly significant, the treatment was well tolerated, and no side effects were recorded.

It can therefore be said that probiotics also demonstrate added value as adjuvants to conventional antibiotics, as they can reduce the gastrointestinal side effects associated with treatment and contribute to improved therapeutic adherence.

 

Antibiotics and the microbiome: effective, but with a real cost

Antibiotics remain one of the mainstays of treatment for moderate to severe acne. Their efficacy has been well established for many years. However, their prolonged use carries two consequences that the scientific community is taking increasingly seriously: on the one hand, the generation of bacterial resistance, and on the other, the impoverishment of both the cutaneous and digestive microbiome. The resistance of C. acnes to erythromycin and tetracycline has increased significantly in recent decades, progressively reducing the efficacy of treatments that previously worked in a predictable manner. Modulation of the microbiome as a complementary strategy (through probiotics, prebiotics, and dietary changes) seeks precisely to reduce long-term dependence on antibiotics.

 

Bacteriophages for acne: the therapy of the future

Bacteriophages are viruses that attack bacteria in a highly selective manner. In the context of acne, researchers are developing phages capable of targeting specifically type IA C. acnes (the most virulent) without affecting the remaining beneficial strains of the cutaneous microbiota. This selectivity makes them a superior alternative to conventional antibiotics. Bacteriophage therapy is still a line of research, but it represents one of the most conceptually significant advances in acne management in recent years.

 

Scientifically grounded habits for caring for your microbiome and improving acne

Caring for the cutaneous and intestinal microbiota does not require supplements alone. Reducing the consumption of simple sugars and high glycaemic index foods, maintaining a facial cleansing routine using pH-neutral products that do not destroy the protective flora, and avoiding the use of antibiotics without medical prescription are all measures with genuine scientific backing. The Mediterranean diet, rich in fibre, antioxidants, and healthy fats, promotes a diverse intestinal microbiome that is reflected positively in skin health. These changes do not replace first-line pharmacological treatment, but they enhance its results and reduce the risk of relapse.

If you suffer from acne and wish to control your flare-ups, it is essential to visit a clinic where a comprehensive assessment can be carried out (one that includes an analysis of the microbiological, hormonal, and dietary factors involved) in order to design a fully personalised treatment plan.